20 August 2010 - Radiometer America announced today that Radiometer’s next-generation, cassette-based analyzer, the ABL90 FLEX, received 510(k) clearance from the U.S. Food and Drug Administration. The ABL90 FLEX analyzer is the latest addition to the company’s blood gas line, offering speed and high-throughput in a compact instrument.

 

The ABL90 FLEX delivers blood gas results in 35 seconds, a turnaround time (TAT) unmatched by other blood gas analyzers on the market. The analyzer also processes up to 44 samples per hour. The short TAT and high-throughput capacity, combined with the analyzer’s time and labor saving features, enable clinical caregivers to spend less time on testing and more on patient care.

 

Ideal for the point of care

Designed specifically for point-of-care (POC) testing, the ABL90 FLEX is a test-select analyzer that measures 16 parameters, including blood gases, electrolytes, metabolites and CO-oximetry, from just 65 μL of whole blood.

 

Equally well-suited to lab or POC applications, the ABL90 FLEX offers automatic quality management (AQM) and easy replacement of consumables.

With a footprint about the area of a sheet of paper, the ABL90 FLEX fits easily within the confines of the hospital’s clinical POC areas.

The ABL90 FLEX was awarded the prestigious 2010 Medical Design Excellence Award in recognition of a design that innovates the face of healthcare as we know it today.

 

About Radiometer

Radiometer is a world leader in the development, manufacturing and distribution of technologically advanced acute care testing solutions. Radiometer’s products and services simplify and automate all phases of acute care testing, so hospitals can get fast results, reduce their workload and the risk of errors, and improve cost effectiveness. Radiometer is a part of the Danaher Corporation (NYSE:DHR).